A Phase 1 Study Evaluating AMG 232 in Advanced Solid Tumors or Multiple Myeloma

Clinical trial NCT01723020 · COMPLETED

Trial details

NCT number: NCT01723020
Sponsor: Kartos Therapeutics, Inc.
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Advanced Malignancy Advanced Solid Tumors Cancer Oncology Oncology Patients Tumors Glioblastoma Multiple Myeloma

Start date: 2012-12-27
Primary completion: 2017-03-15
Enrollment: 107

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.